Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Saba

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The American Journal of Medicine|June 1, 1981
Lithium carbonate in patients with small cell lung cancer receiving combination chemotherapyG H Lyman, C C Williams, D Preston, et al.
Journal - Association of Official Analytical Chemists|January 1, 1990
Determination of total sulfite in shrimp, potatoes, dried pineapple, and white wine by flow injection analysis: collaborative studyJ J Sullivan, T A Hollingworth, M M Wekell, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2023
Identification of COL1A1/2 Mutations and Fusions With Noncoding RNA Genes in Bizarre Parosteal Osteochondromatous Proliferation (Nora Lesion)Yu-Chien Kao, Akihiko Yoshida, Tsung-Han Hsieh, et al.
NPJ Genomic Medicine|September 25, 2024
CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcomaKarim H Saba, Valeria Difilippo, Emelie Styring, et al.
Nature Communications|February 7, 2020
Clonal competition within complex evolutionary hierarchies shapes AML over timeCarl Sandén, Henrik Lilljebjörn, Christina Orsmark Pietras, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
Treatment of poor prognosis AML patients using PSC833 (valspodar) plus mitoxantrone, etoposide, and cytarabine (PSC-MEC)R Advani, G Visani, D Milligan, et al.
The Journal of Pathology|November 27, 2023
Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathwayKarim H Saba, Valeria Difilippo, Michal Kovac, et al.
The Journal of Pathology. Clinical Research|June 17, 2020
Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastomaKarim H Saba, Louise Cornmark, Jakob Hofvander, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The American Journal of Medicine|June 1, 1981
Lithium carbonate in patients with small cell lung cancer receiving combination chemotherapyG H Lyman, C C Williams, D Preston, et al.
Journal - Association of Official Analytical Chemists|January 1, 1990
Determination of total sulfite in shrimp, potatoes, dried pineapple, and white wine by flow injection analysis: collaborative studyJ J Sullivan, T A Hollingworth, M M Wekell, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2023
Identification of COL1A1/2 Mutations and Fusions With Noncoding RNA Genes in Bizarre Parosteal Osteochondromatous Proliferation (Nora Lesion)Yu-Chien Kao, Akihiko Yoshida, Tsung-Han Hsieh, et al.
NPJ Genomic Medicine|September 25, 2024
CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcomaKarim H Saba, Valeria Difilippo, Emelie Styring, et al.
Nature Communications|February 7, 2020
Clonal competition within complex evolutionary hierarchies shapes AML over timeCarl Sandén, Henrik Lilljebjörn, Christina Orsmark Pietras, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
Treatment of poor prognosis AML patients using PSC833 (valspodar) plus mitoxantrone, etoposide, and cytarabine (PSC-MEC)R Advani, G Visani, D Milligan, et al.
The Journal of Pathology|November 27, 2023
Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathwayKarim H Saba, Valeria Difilippo, Michal Kovac, et al.
The Journal of Pathology. Clinical Research|June 17, 2020
Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastomaKarim H Saba, Louise Cornmark, Jakob Hofvander, et al.
Pageof 3